1. Improving the bioactivity of rHirudin with boronophenylalanine site-specific modification.
- Author
-
XIUJUAN XIN, WENSHE LIU, and LIYUN SUN
- Subjects
- *
HIRUDIN , *ESCHERICHIA coli , *AFFINITY chromatography , *ANTITHROMBINS , *TIME-of-flight mass spectrometry , *FIBROBLASTS , *CELL proliferation - Abstract
To improve the bioactivity of recombinant (r) Hirudin, the orthogonal pair MjBTyrRS/tRNATyr cua (made up of the boronophenylalanine, tRNA and tRNA synthetase), was selected to incorporate boronophenylalanine site-specifically into rHirudin at the 63 sites in an Escherichia coli system in response to the TAG codon. Following fusion with the gIII signal peptide and a hexahistidine tag, the modified protein was secreted into Luria-Bertani culture medium and purified by nickel-nitrilotriacetic acid affinity chromatography following a gel filtration column. In a 200 ml flask, the yield of boronophenylalanine-modified hirudin was 10 mg l-1 and that of rHirudin was 19 mg l-1. The authenticity of the purified proteins was verified using matrix-assisted laser desorption ionization time of flight mass spectroscopy and antithrombin activity assays. The results revealed that the antithrombin activity of the boronophenylalanine-modified hirudin to human thrombin was more enhanced than that of rHirudin. The modified hirudin demonstrated stronger proliferation inhibiting ability on fibroblast L929 cells compared with that of rHirudin. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF